These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6233003

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Culture and sensitivity testing of tumors.
    Von Hoff DD, Forseth B, Gonzales L.
    Tex Med; 1986 Sep; 82(9):32-5. PubMed ID: 3775684
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. [Scintillation assay for evaluating chemosensitivities of human tumors--the basic principle and clinical utility].
    Tanigawa N, Takada Y, Morimoto H, Katoh Y, Maruhashi K, Nakanishi M, Tanaka T, Hashimura T, Sondak VK, Kern DH.
    Nihon Gan Chiryo Gakkai Shi; 1985 Jun 20; 20(5):976-83. PubMed ID: 4056552
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Cloning of pediatric malignancies for drug sensitivity testing in the human tumor cloning assay.
    Morris GL, Zeltzer PM, Schneider SL, Von Hoff DD.
    Am J Pediatr Hematol Oncol; 1986 Jun 20; 8(1):52-7. PubMed ID: 3013039
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Preclinical studies with trimetrexate: a review of conclusions and unanswered questions.
    Jackson RC, Leopold WR, Hamelehle KL, Fry DW.
    Semin Oncol; 1988 Apr 20; 15(2 Suppl 2):1-7. PubMed ID: 2966980
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Cell cycle effects of trimetrexate (CI-898).
    Hook KE, Nelson JM, Roberts BJ, Griswold DP, Leopold WR.
    Cancer Chemother Pharmacol; 1986 Apr 20; 16(2):116-20. PubMed ID: 2936525
    [Abstract] [Full Text] [Related]

  • 73. Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.
    Hepburn PJ, Oliver RT, Riley PA, Hill BT, Masters JR.
    Urol Res; 1985 Apr 20; 13(1):27-34. PubMed ID: 4039488
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Anticancer drug activity in human bladder tumor cell lines.
    Niell HB, Webster KC, Smith EE.
    Cancer; 1985 Sep 01; 56(5):1039-44. PubMed ID: 4016694
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Novel chemotherapeutic agents in early clinical development.
    Stagg MP, Diasio RB.
    Curr Opin Oncol; 1990 Dec 01; 2(6):1119-25. PubMed ID: 1983089
    [No Abstract] [Full Text] [Related]

  • 79. Drug sensitivity testing of carcinoma of the gallbladder and biliary tree in a human tumor cloning assay.
    Harris GJ, Von Hoff DD.
    Cancer Drug Deliv; 1986 Dec 01; 3(3):197-204. PubMed ID: 3779604
    [Abstract] [Full Text] [Related]

  • 80. Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens.
    Von Hoff DD, Clark GM, Weiss GR, Marshall MH, Buchok JB, Knight WA, LeMaistre CF.
    J Clin Oncol; 1986 Dec 01; 4(12):1827-34. PubMed ID: 2431110
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.